Clinical Trials on Primary Central Nervous System Hodgkin Lymphoma in Japan

Total 1369 results

Taisho Pharmaceutical Co., Ltd.

Completed

Late Phase II Study of TS-142 in Patients With Insomnia

Patients With Insomnia

Japan
Pfizer

Completed

A Study To Compare The Amount Of Premarin Components That Is Absorbed Into The Blood Of Japanese Healthy Postmenopausal Women Following Oral Administration Of Two Different Tablets Of Premarin Under Fast and Fed Conditions.

Menopause | Vaginitis | Metrorrhagia | Primary Ovarian Insufficiency

Japan
Novo Nordisk A/S

Completed

Factor VIIa in Acute Intracerebral Haemorrhage

Acquired Bleeding Disorder | Intracerebral Haemorrhage

Japan
Teijin Pharma Limited

Completed

A Randomized Placebo-controlled Multicenter Trial to Evaluate the Efficacy and Safety of JTR-161, Allogeneic Human Dental Pulp Stem Cell, in Patients With Acute Ischemic stRoke (J-REPAIR) (J-REPAIR)

Acute Ischemic Stroke

Japan
Eli Lilly and Company

Completed

A Study of LY2951742 (Galcanezumab) in Japanese Participants With Episodic Migraine

Migraine

Japan
Taisho Pharmaceutical Co., Ltd.

Completed

Long-Term Study of TS-142 in Patients With Insomnia

Patients With Insomnia

Japan
Kissei Pharmaceutical Co., Ltd.

Completed

A 24-week Open-label Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)

Spinocerebellar Degeneration

Japan
Kissei Pharmaceutical Co., Ltd.

Completed

A Long-Term Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)

Spinocerebellar Degeneration

Japan
Taisho Pharmaceutical Co., Ltd.

Completed

Phase III Study of TS-142 in Patients With Insomnia

Patients With Insomnia

Japan
Kissei Pharmaceutical Co., Ltd.

Completed

An Extension Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)

Spinocerebellar Degeneration

Japan
Stempeutics Research Pvt Ltd
Stempeutics Research Malaysia SDN BHD

Withdrawn

Ex Vivo Cultured Adult Allogenic MSCs in Ischemic Cerebral Stroke

Stroke

Malaysia
National Hospital Organization Osaka National Hospital
Network for Clinical Stroke Trials; The BMS/Pfizer Japan Thrombosis Investigator...

Recruiting

Optimal Antithrombotic Therapy in Ischemic Stroke Patients With Non-Valvular Atrial Fibrillation and Atherothrombosis (ATIS-NVAF)

Ischemic Stroke | Atrial Fibrillation | Atherothrombosis

Japan
H. Lundbeck A/S

Active, not recruiting

Long-Term Extension Study With Eptinezumab as Preventive Treatment in Participants With Migraine in Japan

Migraine

Japan
Eisai Co., Ltd.

Completed

Investigation of the Safety and Efficacy of Long Term Administration of Eszopiclone in Insomnia Patients

Insomnia

Japan
SNLD, Ltd.

Recruiting

A Phase I Study of TRN501 in Healthy Volunteers

Parkinson Disease

Japan
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating the Safety and Pharmacokinetics of a Single Dose of GSI-953

Healthy

Japan
Pfizer
JANSSEN Alzheimer Immunotherapy Research & Development, LLC

Completed

Study Evaluating ACC-001 in Japanese Patients With Mild To Moderate Alzheimer's Disease

Alzheimer Disease

Japan
Bayer

Completed

Survey on Menstrual Symptoms, Health Related Quality of Life and Work Productivity in Patients Suffering From Pain During Menstruation (Dysmenorrhea) in Japan

Dysmenorrhea

Japan
Eli Lilly and Company

Completed

A Bioequivalence (BE) Study in Healthy Subjects

Attention Deficit Hyperactivity Disorder

Japan
SNLD, Ltd.

Completed

Phase II Clinical Study of TR-012001 in Japanese Patients With Parkinson's Disease

Parkinson Disease

Japan
Kyowa Kirin Co., Ltd.

Completed

A Drug Interaction Study of KW-6356 and Clarithromycin or Rifampicin

Parkinson's Disease

Japan
Takeda

Completed

Ramelteon 8 mg Tablets Specified Drug-use Survey: <Long-term Survey on Insomnia Accompanied by Difficulty Falling Asleep> - Transitional Survey From the Preceding Drug-use Survey -

Insomnia

Japan
Kissei Pharmaceutical Co., Ltd.

Completed

A Phase II Double Blind Comparative Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)

SCD

Japan
National Center of Neurology and Psychiatry, Japan

Completed

Phase II Clinical Trial of OCH-NCNP1

Multiple Sclerosis, Relapsing-Remitting | Multiple Sclerosis, Secondary Progressive

Japan
Eli Lilly and Company
Shionogi

Completed

An Open Label Extension Study of Duloxetine (LY248686) in Participants With Chronic Low Back Pain

Back Pain Lower Back Chronic

Japan
Kyowa Kirin Co., Ltd.

Completed

Observational Study for Non-motor Symptoms and Treatment in Parkinson's Disease Patients (J-FIRST)

Parkinson Disease

Japan
Karthick Balasubramanian

Not yet recruiting

tDCS for Neurological Disability Among Subacute Stroke Survivors to Improve Multiple Domains in Quality of Life

Stroke | Stroke, Ischemic

Saudi Arabia
Novo Nordisk A/S

Completed

Long-term Trial on Growth Hormone Deficiency in Adults (GHDA)

Growth Hormone Disorder | Adult Growth Hormone Deficiency

Japan
Novo Nordisk A/S

Completed

Observational Study of the Safety and Efficacy of Norditropin® in Adult Patients With Growth Hormone Deficiency

Growth Hormone Disorder | Adult Growth Hormone Deficiency

Japan
Eisai Co., Ltd.

Completed

Investigation of the Safety and Efficacy of Eszopiclone in Insomnia Patients

Insomnia

Japan
Eisai Co., Ltd.

Completed

A Bioequivalence and Food Effect Study of SEP-190 in Japanese Healthy Subjects (Study SEP 190-102)

Insomnia

Japan
Chiba University

Completed

Efficacy and Safety of Lenalidomide as a Treatment for Recurrent or Refractory POEMS Syndrome Trial

POEMS Syndrome

Japan
Nobelpharma

Active, not recruiting

Clinical Study of NPC-12Y Gel in Patients With Skin Lesions Associated With TSC

Tuberous Sclerosis Complex

Japan
Eisai Inc.

Completed

A Post-marketing Observational Study on Risk Factors for Hepatic Encephalopathy in Participants With Unresectable Hepatocellular Carcinoma

Carcinoma, Hepatocellular

Japan
W.L.Gore & Associates

Recruiting

Japan Post Marketing Surveillance of the GORE® CARDIOFORM Septal Occluder (GSO-PFO PMS)

Stroke | TIA | Cryptogenic Stroke | PFO - Patent Foramen Ovale

Japan
National Cerebral and Cardiovascular Center, Japan

Completed

Adrenomedullin for CADASIL (AMCAD)

Cadasil

Japan
Novo Nordisk A/S

Completed

Long-term Trial on Growth Hormone Deficiency in Adults (GHDA)

Growth Hormone Disorder | Adult Growth Hormone Deficiency

Japan
Novo Nordisk A/S

Completed

Growth Hormone Deficiency in Adults (GHDA)

Growth Hormone Disorder | Adult Growth Hormone Deficiency

Japan
GlaxoSmithKline

Completed

A Study to Assess the Burden of Herpes Zoster and Postherpetic Neuralgia in Japanese Adults Aged Sixty Years and Above

Herpes Zoster

Japan
Eisai Co., Ltd.

Completed

Post-Marketing Surveillance Study of Eribulin on the Status and Factors for the Development of Peripheral Neuropathy in Japan.

Breast Cancer | HER2-negative Breast Cancer

Japan
InSightec

Unknown

Safety and Initial Effectiveness of Transcranial MR Guided Focused Ultrasound for the Treatment of Parkinson's Disease (TDPD)

Parkinson Disease

China, Japan
GlaxoSmithKline

Completed

Clinical Study of Lamotrigine to Treat Newly Diagnosed Epilepsy

Epilepsy

Korea, Republic of, Japan
Gunma PAZ College
Kanazawa University

Completed

Low Intensity Physical Activity Leads to Improvement in Brachial-ankle Pulse Wave Velocity of Hemiplegics (LIPA)

Physical Activity | Hemiplegia | Motor Activity

Japan
Eli Lilly and Company

Completed

A Study of LY2951742 (Galcanezumab) in Japanese Participants With Migraine

Migraine

Japan
Eisai Co., Ltd.

Completed

Post-marketing Surveillance of Administration of Botulinum Toxin Type B(NerBloc)-Investigation of the Clinical Condition in Patients With Change From Botulinum Toxin Type A

Cervical Dystonia

Japan
Pfizer

Completed

Study to Evaluate the Immunogenicity, Safety, and Tolerability of a Tick-Borne Encephalitis (TBE) Vaccine in Healthy Japanese Participants 1 Year of Age and Older

Tick-Borne Encephalitis

Japan
Genzyme, a Sanofi Company

Completed

A Long Term Safety and Efficacy Study of Fabrazyme Replacement Therapy in Japanese Patients With Fabry Disease.

Fabry Disease

Japan
Surugadai Nihon University Hospital
Teikyo University

Completed

Microperimetric Evaluation After Half-dose Photodynamic Therapy for Chronic Central Serous Chorioretinopathy

Chronic Central Serous Chorioretinopathy

Japan
Kyoto University
Pfizer; Kitasato University; Tokushima University; Tottori University

Recruiting

iPSC-based Drug Repurposing for ALS Medicine (iDReAM) Study

Amyotrophic Lateral Sclerosis

Japan
Novo Nordisk A/S

Recruiting

Special Use-results Surveillance on Long Term Use of Sogroya® in Children With Short Stature Due to Growth Hormone Deficiency Where Epiphysial Discs Are Not Closed

Growth Hormone Deficiency in Children

Japan

3

Subscribe